-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G7pT3hlTde0Adnr/BFNGa83vxOwKGEo7O1GO4AoVFPmAejRj8MTHpLEsz2XhmrvT P1eOdQ0eciyw5xHfmfGapw== 0001209191-05-012434.txt : 20050228 0001209191-05-012434.hdr.sgml : 20050228 20050228150037 ACCESSION NUMBER: 0001209191-05-012434 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050224 FILED AS OF DATE: 20050228 DATE AS OF CHANGE: 20050228 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOSE TECHNOLOGIES INC CENTRAL INDEX KEY: 0000877902 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133549286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 102 WITMER RD CITY: HORSHAM STATE: PA ZIP: 19044 BUSINESS PHONE: 2154415890 MAIL ADDRESS: STREET 1: 102 WITMER ROAD CITY: HORSHAM STATE: PA ZIP: 19044 FORMER COMPANY: FORMER CONFORMED NAME: NEOSE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLARKE C BOYD CENTRAL INDEX KEY: 0001182504 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27718 FILM NUMBER: 05645023 BUSINESS ADDRESS: STREET 1: C/O NEOSE TECHNOLGIES INC STREET 2: 102 WITMER ROAD CITY: HORSHAM STATE: PA ZIP: 19044 BUSINESS PHONE: 2153159000 MAIL ADDRESS: STREET 1: C/O NEOSE TECHNOLOGIES INC STREET 2: 102 WITMER ROAD CITY: HORSHAM STATE: PA ZIP: 19044 4 1 bop06283_bop16cbc.xml MAIN DOCUMENT DESCRIPTION X0202 4 2005-02-24 0000877902 NEOSE TECHNOLOGIES INC NTEC 0001182504 CLARKE C BOYD 102 WITMER ROAD HORSHAM PA 19044 1 1 0 0 President and CEO Non-Qualified Stock Option (right to buy) 4.2200 2005-02-24 4 A 0 200000 4.2200 A 2015-02-24 Common Stock 200000 200000 D Grant to reporting person of option to buy 200,000 shares, of which 50,000 become exercisable on February 24, 2006, 50,000 shares become exercisable on February 24, 2007, 50,000 become exercisable on February 24, 2008, and 50,000 become exercisable on February 24, 2009. C. Boyd Clarke 2005-02-28 -----END PRIVACY-ENHANCED MESSAGE-----